Erin Collins is a seasoned professional in biologics and drug development with over a decade of experience at Precigen, currently serving as Sr. Director of CMC Biologics/MSAT. Erin has a proven track record in managing multiple GXP-level projects and coordinating with CMOs and CROs across diverse platforms. Prior roles at Precigen include Director and Senior Manager of CMC Biologics, where Erin oversaw drug development initiatives. Earlier experience includes serving as Senior Lab Manager and Lab Manager, focused on high-throughput DNA production and cloning. Erin's career began at the University of Iowa Hospitals and Clinics, where roles included Research Assistant II and Lab Assistant, contributing to viral production and studying HPV-related cervical cancers. Erin holds a BS degree in Microbiology from the University of Iowa.